• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ulcerative colitis (UC) - Articles and news items

sb5

Samsung Bioepis seeks EU approval for its biosimilar adalimumab candidate, SB5

Industry news / 18 July 2016 / Victoria White, Digital Content Producer

At an estimated $4billion a year, the reference product, Humira, is among the European Union’s largest single drug expenditures…

flixabi

Infliximab biosimilar Flixabi approved in the EU

Industry news / 31 May 2016 / Victoria White, Digital Content Producer

The EC has granted marketing authorisation in the European Union (EU) for Flixabi, an infliximab biosimilar referencing Remicade…

uc

New data for vedolizumab in UC presented at DDW

Industry news / 24 May 2016 / Victoria White, Digital Content Producer

Vedolizumab is the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active UC…

adacolumn

New data show clinical benefit of Adacolumn in UC

Industry news / 24 May 2016 / Victoria White, Digital Content Producer

Prof. Dr. Axel Dignass said the data show that Adacolumn provided clinical benefit in steroid-dependent patients with UC with previous failure to biologics…

inflectra

FDA approves Inflectra (biosimilar infliximab) in the US

Industry news / 6 April 2016 / Victoria White, Digital Content Producer

With this approval, Celltrion’s Inflectra becomes the first biosimilar monoclonal antibody (mAb) medication to receive approval in the US…

GO-COLITIS

MSD presents data from Simponi GO-COLITIS trial

Industry news / 21 March 2016 / Victoria White

GO-COLITIS evaluated the efficacy of Simponi (golimumab) in inducing and maintaining clinical response in patients with moderate to severe ulcerative colitis…

AbbVie Logo

AbbVie presents results from large global study of patient attitudes and adherence across six chronic inflammatory diseases

Industry news / 11 June 2014 / AbbVie

AbbVie announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated inflammatory diseases…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +